False positive hepatitis B test results occur more often than most people expect, and they stem from a surprisingly wide range of causes. A screening test that uses antibodies to detect the hepatitis B surface antigen (HBsAg) can be tripped up by anything from a recent vaccination to a supplement you picked up at the pharmacy. In some clinical settings, more than half of initially reactive low-positive results turn out to be false alarms on confirmatory testing, which makes understanding why these errors happen genuinely useful for anyone staring at an unexpected result.
How Screening Tests Get Fooled
Most hepatitis B screening relies on immunoassays, which work by using engineered antibodies designed to latch onto the hepatitis B surface antigen if it is present in your blood. When the antigen binds, the test generates a measurable signal. The problem is that other substances in your blood can sometimes mimic that binding or physically interfere with the reaction, producing a signal even when no hepatitis B virus is there.
Two common platforms are enzyme-linked immunosorbent assays (ELISAs) and chemiluminescent immunoassays (CLIAs). CLIAs are generally more accurate, with specificity around 99.8% compared to roughly 98.5% for ELISAs, but even that small gap matters when you are screening large populations with low infection rates.1Journal of Hematology and Allied Sciences. Discrepancies in hepatitis B surface antigen testing: A systematic review of false-positive results and underlying mechanisms with implications for laboratory hematology A test that is wrong only one or two times out of a thousand sounds excellent until you run it on tens of thousands of people who do not actually have the virus. In that scenario, the handful of errors can outnumber the true positives.
Heterophilic Antibodies
One of the best-documented causes of false positive HBsAg results is interference from heterophilic antibodies. These are rogue antibodies your immune system produces that happen to bind to the animal-derived antibodies used inside the test kit. The result is a signal that looks exactly like a true positive, even though no hepatitis B antigen is present.
A well-documented case demonstrated this clearly: a patient with no clinical signs of hepatitis B returned a reactive HBsAg result, but serial dilutions and retesting on a different commercial platform both pointed to a false positive. When the lab used tubes designed to block heterophilic antibodies, the signal disappeared.2PubMed Central. An Interesting Case of Isolated False-Reactive Hepatitis B Surface Antigen The takeaway is that heterophilic antibody interference can produce an isolated HBsAg positive with every other hepatitis B marker coming back negative, a pattern that should raise suspicion.
A striking cluster of false positives was found among workers at a pork processing plant. Five employees screened positive for HBsAg, yet every one of them tested negative on the confirmatory neutralization assay, and those who had viral load testing done showed no detectable hepatitis B DNA.3Journal of Clinical Virology Plus. False-positive HIV and viral hepatitis serologic test results in a cluster of pork processing plant workers The investigators suspected that occupational exposure to animal proteins triggered antibody responses that cross-reacted with the test reagents. While that kind of occupational cluster is unusual, it illustrates how environmental protein exposure can fool immunoassays in ways no one anticipates.
Recent Hepatitis B Vaccination
This one catches people off guard regularly. The hepatitis B vaccine works by injecting a form of the surface antigen itself, so if your blood is drawn too soon after vaccination, the test may simply be detecting the vaccine antigen rather than actual infection. In one study where blood was drawn on the same day as vaccination, about 2.5% of recipients tested positive for HBsAg, but every one of those positives resolved to negative within a week.4PubMed Central. False positive Hepatitis B Surface Antigen due to recent vaccination
The issue is especially tricky in patients on hemodialysis, who receive both regular hepatitis B vaccinations and frequent blood testing as part of routine monitoring. In these patients, transient HBsAg positivity after vaccination can trigger serious concern about possible viral transmission in the dialysis unit. Experts recommend avoiding HBsAg testing within two to four weeks of vaccination to prevent this confusion.5PubMed Central. False-Positive Hepatitis B Antigenemia After Vaccination in a Patient With CKD If you have recently been vaccinated and are asked to give blood for hepatitis B screening, mentioning the timing to your doctor can save everyone a lot of unnecessary worry.
Non-Hepatitis B Vaccines
The hepatitis B vaccine is the obvious culprit, but it is not the only vaccine linked to false positive HBsAg results. At least one documented case involved a long-time blood donor who tested reactive for HBsAg just two days after receiving a seasonal influenza vaccine. The initial result was confirmed positive by neutralization testing, which made it especially confusing, but subsequent testing showed no hepatitis B DNA and the antigenemia resolved on its own. The investigators noted a seasonal pattern of repeat-reactive HBsAg results among blood donors that coincided with influenza vaccination season, suggesting the phenomenon may be underrecognized.6Transfusion and Apheresis Science. Neutralization positive but apparent false-positive hepatitis B surface antigen in a blood donor following influenza vaccination The mechanism is not fully understood, but the immune activation triggered by any vaccine could, in rare cases, produce short-lived cross-reactive proteins.
Pregnancy
Pregnant women are routinely screened for hepatitis B because the virus can be transmitted to the baby during delivery. Unfortunately, pregnancy is also a setting where false positives are disproportionately common. In a study that investigated discrepant HBsAg results among pregnant women, roughly 84% of the initially positive cases that were followed up turned out to be false positives.7PubMed. Discrepant hepatitis B surface antigen results in pregnant women screened to identify hepatitis B virus infection
The reasons are not entirely clear, but pregnancy involves significant immune system changes and shifts in circulating protein levels that can interfere with immunoassay chemistry. A false positive HBsAg during pregnancy has real consequences: the newborn may receive hepatitis B immune globulin unnecessarily, the mother may be told she has a chronic infection she does not have, and breastfeeding decisions may be affected. Because the stakes are high, confirmatory testing for any positive result during pregnancy is particularly important.
Autoimmune Conditions and Rheumatoid Factor
People with autoimmune diseases, especially rheumatoid arthritis, produce antibodies that are known troublemakers in lab testing. Rheumatoid factor, an antibody directed against the body’s own immunoglobulins, can bind to test reagents and generate false signals. A case report in a patient with seropositive rheumatoid arthritis illustrates the problem: initial screening detected hepatitis B e-antibody and core antibody, but on repeat testing six months later, the e-antibody result had flipped to negative and the core antibody showed only very low-level reactivity on one of two assays. The clinical team concluded that the original results were likely false positives caused by cross-reactivity, given the patient’s extremely high rheumatoid factor and anti-CCP antibody levels.8Rheumatology. False-Positive Hepatitis B Serology Due to Suspected Cross-Reactivity in a Patient with Rheumatoid Arthritis
This matters because many patients with autoimmune conditions are considered for immunosuppressive therapies, and a positive hepatitis B result can delay or alter treatment. If someone with known high rheumatoid factor tests positive on a hepatitis B screen, clinicians should treat the result with extra skepticism and pursue confirmatory testing before making treatment decisions.
Biotin Supplements
Biotin, also sold as vitamin B7 or vitamin H, has become a popular supplement for hair, skin, and nail health. It also happens to be a key molecule in the chemistry of many immunoassays. Some test platforms use biotin-streptavidin binding as part of their detection system, and when your blood contains high levels of supplemental biotin, it can compete with the test’s own biotin, throwing off results.
The direction of interference depends on the assay design. In one study, biotin intake led to false positive results for hepatitis B core antibody in 90% of tested cases and false positive hepatitis B e-antibody in 80% of cases. The same biotin exposure caused false negative results for hepatitis B surface antibody in 40% of cases, meaning it simultaneously made people look infected when they were not and unprotected when they actually were.9PubMed. Biotin interferences: Have we neglected the impact on serological markers? If you take biotin supplements, especially at doses above 5 milligrams per day, let your doctor know before any blood work. Most labs recommend stopping biotin at least 48 to 72 hours before testing.
Passive Antibody Transfer from Blood Products
Intravenous immunoglobulin (IVIG) is a treatment made from pooled donor plasma, and it carries antibodies from hundreds or thousands of donors. Some of those donors will have been exposed to hepatitis B, meaning the IVIG contains hepatitis B core antibody even though no live virus is present. When a patient receives IVIG, those passively transferred antibodies can show up on subsequent testing and look like evidence of a hepatitis B infection.
A retrospective study of cancer patients who received IVIG found that about 15% of patients who were previously negative for hepatitis B core antibody became positive after infusion. The probability of testing positive was highest shortly after treatment, around 34% at one week, and dropped to about 4% by twelve weeks. None of the patients who converted actually developed hepatitis B surface antigen positivity or detectable viral DNA.10PubMed Central. Passive Transfer of Hepatitis B Core Antibody after Intravenous Immunoglobulin Administration in Patients with Cancer: Retrospective Chart Review The same phenomenon has been documented in newborns treated with IVIG, where passive transfer of core antibody was confirmed when the result spontaneously reverted weeks later.11PubMed. Passive Transfer of Hepatitis B Antibodies through Intravenous Immunoglobulin in a Neonate
This is a situation where knowing the patient’s treatment history is critical. A new hepatitis B core antibody positive result in someone who recently received IVIG should not trigger panic or antiviral treatment. Retesting after a few months will usually show the antibody has cleared.
The Isolated Core Antibody Problem
One of the most common and confusing patterns in hepatitis B testing is an isolated positive result for hepatitis B core antibody (anti-HBc) with everything else negative. This can mean several different things: a resolved past infection where surface antibody has waned, an occult ongoing infection with very low viral levels, or simply a false positive. Among volunteer blood donors, the vast majority of isolated anti-HBc results turn out to be false positives.12PubMed Central. The frequency and significance of isolated hepatitis B core antibody and the suggested management of patients
The clinical challenge is that you cannot tell which explanation is correct from the single result alone. It requires additional testing, typically including hepatitis B DNA testing and sometimes a hepatitis B surface antibody level after a vaccine booster dose, to sort out whether the core antibody is meaningful. For otherwise healthy people in low-risk populations, a false positive is the most likely explanation, but for people with risk factors for hepatitis B exposure, the result deserves closer investigation.
Why Confirmatory Testing Matters So Much
Given how many things can cause false positives, the standard practice after any reactive hepatitis B screening result is confirmatory testing. The most common confirmatory method is the neutralization assay, which adds specific antibodies to the sample to see whether they can block the signal. If the signal drops significantly, the original result is confirmed as a true positive. If it does not drop, the original result was likely a false positive.
The numbers from confirmatory testing studies are eye-opening. In one five-year study of initially reactive specimens with low-positive signal values, only about 46% were confirmed positive by the neutralization assay, meaning more than half were false positives.13PubMed. Need for Confirmatory Neutralization Tests for Hepatitis B Surface Antigen Tests in Populations with Intermediate Prevalence A similar study using a different commercial platform found that among borderline samples, about 53% were confirmed, and most of the unconfirmed false positives had very low initial signal values.14PubMed. Resolving Uncertainty in Hepatitis B Diagnosis: Evaluating Neutralization Testing for Borderline HBsAg The pattern is consistent: the lower the initial signal, the more likely it is to be a false positive. A weakly reactive screening result is not the same thing as a diagnosis.
Other confirmatory approaches include testing for hepatitis B DNA by PCR, which directly detects the virus’s genetic material and is not subject to the same antibody-based interference. A negative DNA test in someone with a positive HBsAg screening result is strong evidence that the screening result was wrong, though there are rare situations like very early acute infection where DNA levels can briefly be undetectable.
False Positives in Blood Donor Screening
Blood banks screen every donation for hepatitis B, and they intentionally use highly sensitive assays to protect the blood supply. The trade-off is that higher sensitivity comes with more false positives. In a study of blood donation screening over multiple years, about 18% of positive HBV screening results were false positives, a lower rate than for HIV screening (where about 92% of positives were false) or HCV screening (about 73% false positive), but still a meaningful number.15PubMed Central. False-positive test results: prevalence, time trends, and factors associated with false-positive serological markers in blood donation screening
For blood donors, a false positive result can mean permanent deferral from donating, which is frustrating for people who have been regular donors for years. Some blood services have protocols for reinstating donors after confirmatory testing clears them, but the process varies by organization and can take months.
Rapid and Point-of-Care Tests
Rapid diagnostic tests for hepatitis B, the kind that give results in minutes using a finger-prick blood sample, are widely used in resource-limited settings and community screening programs. They are convenient but generally less accurate than laboratory-based immunoassays. In one evaluation, rapid immunoassay chromatographic testing produced a small number of false positives alongside some false negatives, with two false positive results out of 117 truly negative samples.16PubMed Central. Sensitivity and Specificity of Hepatitis B Virus Screening via Rapid Immunoassay Chromatographic Test While that rate may sound low, it reinforces the principle that any positive rapid test should be confirmed with a laboratory-based assay before a diagnosis is made or treatment is started.
Rapid tests are also more vulnerable to operator error, storage conditions, and expired reagents than automated laboratory platforms. In field settings with high temperatures or inconsistent supply chains, performance can drift further from what the manufacturer’s specifications promise.
What to Do If You Get an Unexpected Positive
If you receive a reactive hepatitis B screening result and it does not match your risk profile or clinical picture, several practical steps can help sort out whether it is real. First, ask whether confirmatory testing has been done. A screening result alone is not a diagnosis, and many labs automatically reflex to a neutralization assay, but not all do. Second, tell your doctor about any recent vaccinations, IVIG infusions, biotin supplements, or autoimmune conditions, because each of these can explain a false positive and guide the follow-up strategy. Third, hepatitis B DNA testing by PCR provides an independent check that sidesteps the antibody-based interference problems entirely.
If the confirmatory test is negative and DNA is undetectable, you can be reassured that the original result was a false positive. Some clinicians will recommend repeating the full panel in a few weeks to make sure nothing was missed, particularly if there is any plausible exposure history. For pregnant women, the urgency of getting the confirmatory answer quickly is higher because decisions about newborn prophylaxis need to happen around the time of delivery.
When Timing Creates Confusion
Several causes of false positives are inherently time-limited. Vaccine-related antigenemia clears within days to a few weeks. Passive antibody transfer from IVIG fades over weeks to months. Even heterophilic antibody interference can fluctuate. This means that a repeat test drawn at the right interval will often resolve the question on its own. The flip side is that if the timing of the repeat test is too close to the original, the same interference may still be present, and the result may still look positive.
For post-vaccination false positives, waiting at least two weeks and ideally four weeks before retesting is the standard advice. For IVIG-related false positives, retesting after about three months gives the passively transferred antibodies time to clear. For biotin interference, stopping the supplement for three days before the blood draw is usually sufficient. Knowing these windows prevents unnecessary repeat testing and avoids the anxiety of seeing the same “positive” result come back when the underlying cause has not yet resolved.